35 pending office actions • 19 clients • 34 examiners • 25 art units • 0 of 35 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (6%) |
| §103 only | 18 (51%) |
| §102 only | 4 (11%) |
| §112 only | 6 (17%) |
| Double-patenting only | 3 (9%) |
| No statute on record | 2 (6%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEFFLEY, MICHAEL F | 2 | 77.6% | +12.9% |
| UPCHURCH, DAVID M | 1 | 73.6% | +17.9% |
| ABDOSH, SAMIR | 1 | 83.9% | +6.4% |
| HOLLOMAN, NANNETTE | 1 | 60.7% | +22.9% |
| ELDRED, JOHN W | 1 | 77.6% | +7.9% |
| KOBYLARZ, ANDREW M | 1 | 76.7% | +19.9% |
| SHAKERI, HADI | 1 | 62.1% | +37.2% |
| GUILLERMETY, JUAN M | 1 | 72.4% | +14.3% |
| SCHWARZENBERG, PAUL | 1 | 61.9% | +28.5% |
| DANIEL JR, WILLIE J | 1 | 60.9% | +20.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19115175 | FINGER SUPPORT THAT CAN BE ATTACHED TO AND REMOVED FROM FIREARMS | ABDOSH, SAMIR | 18d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18679327 | FINANCIAL TRANSACTION FRAUD PREVENTION SYSTEM USING HYSTERESIS MODELS, DECISION TREES, AND TRANSFORMER NETWORKS | SCHWARZENBERG, PAUL | 33d |
| 16095563 | METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS | CHEONG, CHEOM-GIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18739123 | PRINTING FROM A HANDHELD DEVICE VIA A REMOTE SERVER | GUILLERMETY, JUAN M | 88d overdue |
| 18131759 | BLADDER TISSUE MODIFICATION FOR OVERACTIVE BLADDER DISORDERS | PEFFLEY, MICHAEL F | 52d overdue |
| 18571421 | Method and apparatus for wireless synchronization of mobile devices | DANIEL JR, WILLIE J | 38d overdue |
| 18956263 | SPACER FOR RESISTANCE ADJUSTMENT IN RESISTANCE TRAINING APPARATUS | KOBYLARZ, ANDREW M | 19d |
| 17990634 | DEVICES AND METHODS FOR TRANSURETHRAL BLADDER PARTITIONING | PEFFLEY, MICHAEL F | 20d |
| 18679327 | FINANCIAL TRANSACTION FRAUD PREVENTION SYSTEM USING HYSTERESIS MODELS, DECISION TREES, AND TRANSFORMER NETWORKS | SCHWARZENBERG, PAUL | 33d |
| 19120187 | A MULTI-PURPOSE TACTICAL UNIFORM LOCK THAT IS EASILY ATTACHED AND DETACHED | UPCHURCH, DAVID M | — |
| 19064180 | METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS | HOLLOMAN, NANNETTE | — |
| Art Unit | Apps |
|---|---|
| 3794 | 3 |
| 3641 | 2 |
| 1623 | 2 |
| 1645 | 2 |
| 3783 | 2 |
| 1641 | 2 |
| 1611 | 2 |
| 3677 | 1 |
| 3784 | 1 |
| 2682 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19120187 | A MULTI-PURPOSE TACTICAL UNIFORM LOCK THAT IS EASILY ATTACHED AND DETACHED | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | UPCHURCH, DAVID M | 3677 | §102 | Non-Final OA | — | Pending | Apr 10, 2025 |
| 19115175 | FINGER SUPPORT THAT CAN BE ATTACHED TO AND REMOVED FROM FIREARMS | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | ABDOSH, SAMIR | 3641 | §102 | Non-Final OA | 18d overdue | Pending | Mar 25, 2025 |
| 19064180 | METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS | Respira Therapeutics, Inc. | HOLLOMAN, NANNETTE | DP | Non-Final OA | — | Pending | Feb 26, 2025 | |
| 18869920 | A GRIP DESIGN WITH AN INSERT MANUFACTURED IN ONE PIECE BY INJECTION | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | ELDRED, JOHN W | 3641 | §103 | Final Rejection | 8d | Pending | Nov 27, 2024 |
| 18956263 | SPACER FOR RESISTANCE ADJUSTMENT IN RESISTANCE TRAINING APPARATUS | Harambe System LLC | KOBYLARZ, ANDREW M | 3784 | §103 | Non-Final OA | 19d | Pending | Nov 22, 2024 |
| 18838985 | GUN-SHAPED SCREWING APPARATUS WHICH COMPRISES A TOOLBOX WITHIN AND WHICH CAN BE USED FOR THE ASSEMBLY OF FIREARM ACCESORIES | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | SHAKERI, HADI | §103 | Non-Final OA | — | Pending | Aug 15, 2024 | |
| 18739123 | PRINTING FROM A HANDHELD DEVICE VIA A REMOTE SERVER | Quest Diagnostics Investments LLC | GUILLERMETY, JUAN M | 2682 | §103 | Non-Final OA | 88d overdue | Pending | Jun 10, 2024 |
| 18679327 | FINANCIAL TRANSACTION FRAUD PREVENTION SYSTEM USING HYSTERESIS MODELS, DECISION TREES, AND TRANSFORMER NETWORKS | Givecorporation, Inc. | SCHWARZENBERG, PAUL | 3695 | §101 | Final Rejection | 33d | Pending | May 30, 2024 |
| 18571421 | Method and apparatus for wireless synchronization of mobile devices | Sennheiser Electronic SE & Co. Kg | DANIEL JR, WILLIE J | 2465 | §102 | Non-Final OA | 38d overdue | Pending | Dec 18, 2023 |
| 18568249 | MACROCYCLIC TAK1 INHIBITORS | Aqilion AB | LEE, WILLIAM Y | 1623 | §112 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18287096 | FORMULATIONS OF CANNABINOIDS | Add Advanced Drug Delivery Technologies Ltd. | CHONG, YONG SOO | 1623 | §103 | Final Rejection | 52d overdue | Pending | Oct 16, 2023 |
| 18275351 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DYING FROM BREAST CANCER OR PROSTATE CANCER | Nightingale Health Oyj | WECKER, JENNIFER | 1797 | §103 | Non-Final OA | 42d | Pending | Aug 01, 2023 |
| 18338805 | METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS | 4TEEN4 Pharmaceuticals GmbH | KARUNASENA, ENUSHA | 1645 | DP | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18198228 | Method and Apparatus for Storing Energy | King Saud University | NASSER, ROBERT L | 3992 | §112 | Non-Final OA | 50d | Pending | May 16, 2023 |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | Public University Corporation Nagoya City University | BUCHANAN, BAILEY CHEYENNE | 1682 | §102 | Final Rejection | — | Pending | May 12, 2023 |
| 18131759 | BLADDER TISSUE MODIFICATION FOR OVERACTIVE BLADDER DISORDERS | Newuro, B.V. | PEFFLEY, MICHAEL F | 3794 | §103 | Final Rejection | 52d overdue | Pending | Apr 06, 2023 |
| 18027883 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | TriSalus Life Sciences, Inc. | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Final Rejection | 32d overdue | Pending | Mar 22, 2023 |
| 18027895 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | TriSalus Life Sciences, Inc. | WHITEMAN, BRIAN A | 1636 | §103 | Non-Final OA | 21d | Pending | Mar 22, 2023 |
| 18087767 | SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER | TriSalus Life Sciences, Inc. | PATEL, SHEFALI DILIP | 3783 | §112 | Non-Final OA | 28d | Pending | Dec 22, 2022 |
| 18087508 | SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE | TriSalus Life Sciences, Inc. | JIAN, SHIRLEY XUEYING | 3792 | §103 | Non-Final OA | — | Pending | Dec 22, 2022 |
| 18011082 | METHOD FOR DETERMINING WHETHER A SUBJECT HAS A DISEASE OR CONDITION OR IS AT RISK OF DEVELOPING A DISEASE OR CONDITION | Nightingale Health Oyj | FRITCHMAN, REBECCA M | 1758 | §112 | Non-Final OA | 9d overdue | Pending | Dec 16, 2022 |
| 17992433 | THERAPEUTIC TREATMENT DEVICE WITH BRAIDED-STRAND MICROVALVE OCCLUDER HAVING MODIFIED FILTER COATING | TriSalus Life Sciences, Inc. | HOUSTON, ELIZABETH | 3771 | §103 | Final Rejection | — | Pending | Nov 22, 2022 |
| 17990634 | DEVICES AND METHODS FOR TRANSURETHRAL BLADDER PARTITIONING | Newuro, B.V. | PEFFLEY, MICHAEL F | 3794 | §103 | Final Rejection | 20d | Pending | Nov 18, 2022 |
| 17984611 | DPP3 BINDER DIRECTED TO AND BINDING TO SPECIFIC DPP3-EPITOPES AND ITS USE IN THE PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS THAT ARE ASSOCIATED WITH OXIDATIVE STRESS | 4TEEN4 Pharmaceuticals GmbH | WEN, SHARON X | 1641 | Other | Non-Final OA | 45d overdue | Pending | Nov 10, 2022 |
| 17953152 | DEVICES AND METHOD FOR FAR FIELD BIPOLAR ABLATION | Newuro, B.V. | SHOULDERS, ANNIE LEE | 3794 | §103 | Final Rejection | 4d overdue | Pending | Sep 26, 2022 |
| 17802799 | DPP3 FOR THERAPY GUIDANCE, MONITORING AND STRATIFICATION OF NT-ADM ANTIBODIES IN PATIENTS WITH SHOCK | 4TEEN4 Pharmaceuticals GmbH | AEDER, SEAN E | 1642 | §112 | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17602356 | PROCESS FOR CONTINUOUS PRODUCTION OF AN ACTIVE INGREDIENT GRANULATE | Add Advanced Drug Delivery Technologies Ltd. | JANOSKO, CHASITY PAIGE | 1613 | §103 | Final Rejection | 23d overdue | Pending | May 25, 2022 |
| 17769398 | CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES | Add Advanced Drug Delivery Technologies Ltd. | BAEK, BONG-SOOK | 1611 | §103 | Final Rejection | 67d overdue | Pending | Apr 15, 2022 |
| 17637518 | THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF SHOCK | 4TEEN4 Pharmaceuticals GmbH | TAYLOR, LIA ELAN | 1641 | DP | Final Rejection | — | Pending | Feb 23, 2022 |
| 17622187 | DIGITAL CERTIFICATE PROCESSING METHOD, GATEWAY, DEVICE, SYSTEM, MEDIUM, AND PROGRAM PRODUCT | Antpool Technologies Limited | QAYYUM, ZESHAN | 3697 | §112 | Final Rejection | — | Pending | Dec 22, 2021 |
| 17557132 | THERAPEUTIC PILLOW | Invicta Watch Company Of America, Inc. | SUN, GEORGE | 3673 | §103 | Non-Final OA | 98d overdue | Pending | Dec 21, 2021 |
| 17610127 | METHODS AND SYSTEMS FOR PROTEIN ENGINEERING AND PRODUCTION | Labgenius Ltd. | PLAYER, ROBERT AUSTIN | 1686 | §103 | Final Rejection | — | Pending | Nov 09, 2021 |
| 17236446 | Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change | TriSalus Life Sciences, Inc. | MEDWAY, SCOTT J | 3783 | §103 | Non-Final OA | 11d overdue | Pending | Apr 21, 2021 |
| 16513238 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | Glatt GmbH | ALAM, AYAAN A | 1611 | Other | Non-Final OA | 45d overdue | Pending | Jul 16, 2019 |
| 16095563 | METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS | 4TEEN4 Pharmaceuticals GmbH | CHEONG, CHEOM-GIL | 1645 | §101 | Final Rejection | — | Pending | Oct 22, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial